Thomas W McMullin

This inventor holds 13 USPTO granted patents and 2 published patent applications. Top assignees: Arkion Life Sciences, LLC, Bio-Technical Resources, a Division of Arkion Life Sciences, LLC, Dcv, Inc.. Active years: 2001-2015.

USPTO Granted Patents = 13 (Patent Applications = 2)

% Patents Active = 30.8

Average Co-Inventor Count = 3.2

ph-index = 7

Forward Citations = 294(Granted Patents)

Location History:

Maintowoc, WI (US) (2002)
Manitowoc, WI (US) (2001 - 2015)

Company Filing History:

7 out of 31

Arkion Life Sciences, LLC

patents

4 out of 4

Bio-Technical Resources, a Division of Arkion Life Sciences, LLC

4. 1 out of 834,411

Other

patents

Years Active: 2001-2015

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9102954 - Production of isoprenoids (2015-08-11),

2. 8241888 - Production of isoprenoids (2012-08-14),

3. 8236552 - Production of isoprenoids (2012-08-07),

4. 7927862 - Production of isoprenoids (2011-04-19),

5. 7927861 - Production of isoprenoids (2011-04-19),

6. 7842497 - Production of isoprenoids (2010-11-30),

7. 7838279 - Production of isoprenoids (2010-11-23),

8. 7732161 - Production of isoprenoids (2010-06-08),

9. 7718417 - Production of isoprenoids (2010-05-18),

10. 6689593 - Production of farnesol and geranylgeraniol (2004-02-10),

11. 6531303 - Method of producing geranylgeraniol (2003-03-11),

12. 6410755 - Method of vitamin production (2002-06-25),

13. 6242227 - Method of vitamin production (2001-06-05),

Title: Thomas W McMullin: Pioneering Innovations in Isoprenoid Production

Introduction:

Thomas W McMullin, a prolific inventor hailing from Manitowoc, WI, has left an indelible mark in the field of biotechnology with his groundbreaking work on isoprenoid production. With a total of 13 patents to his name, McMullin's contributions have revolutionized the biological methods of producing isoprenoids.

Latest Patents:

One of McMullin's recent patents involves the development of a recombinant yeast that enhances the production of isoprenoid compounds. By optimizing the carbon flow through the mevalonate pathway, this innovation ensures a more efficient synthesis process compared to traditional methods.

Career Highlights:

McMullin has been associated with esteemed companies like Arkion Life Sciences, LLC and Bio-technical Resources. His tenure with these organizations has provided him with the platform to research and implement cutting-edge technologies in the field of biotechnology, particularly in isoprenoid production.

Collaborations:

Throughout his career, McMullin has collaborated with distinguished professionals such as James R Millis and Julie Maurina-Brunker. Together, they have worked on various projects aimed at pushing the boundaries of innovation in biotechnology and enhancing the capabilities of isoprenoid production methods.

Conclusion:

In conclusion, Thomas W McMullin's inventive spirit and dedication to advancing biotechnological processes have solidified his reputation as a trailblazer in the field. His patents and collaborations stand as a testament to his drive for innovation and his significant contributions to the scientific community.